Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131


Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.

Shiels MS, Cole SR, Wegner S, Armenian H, Chmiel JS, Ganesan A, Marconi VC, Martinez-Maza O, Martinson J, Weintrob A, Jacobson LP, Crum-Cianflone NF.

J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):485-90. doi: 10.1097/QAI.0b013e31817dc42b.


Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.

Cobucci RN, Lima PH, de Souza PC, Costa VV, Cornetta Mda C, Fernandes JV, Gonçalves AK.

J Infect Public Health. 2015 Jan-Feb;8(1):1-10. doi: 10.1016/j.jiph.2014.08.003. Review.


A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.

Shiels MS, Cole SR, Chmiel JS, Margolick J, Martinson J, Zhang ZF, Jacobson LP.

J Clin Epidemiol. 2010 Apr;63(4):459-67. doi: 10.1016/j.jclinepi.2009.08.003.


Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort..

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.


Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS)..

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530.


Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer..

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.


AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study..

J Natl Cancer Inst. 2007 Jun 20;99(12):962-72.


Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.

Jacobson LP, Yamashita TE, Detels R, Margolick JB, Chmiel JS, Kingsley LA, Melnick S, Muñoz A.

J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S34-41.


Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.

Cain LE, Cole SR, Chmiel JS, Margolick JB, Rinaldo CR Jr, Detels R.

Am J Epidemiol. 2006 Feb 15;163(4):310-5.


Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.

Schwarcz L, Chen MJ, Vittinghoff E, Hsu L, Schwarcz S.

AIDS. 2013 Feb 20;27(4):597-605. doi: 10.1097/QAD.0b013e32835b0fa2.


Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.


Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

Mocroft A, Sabin CA, Youle M, Madge S, Tyrer M, Devereux H, Deayton J, Dykhoff A, Lipman MC, Phillips AN, Johnson MA.

J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):401-7.


Long-term cancer risk among people diagnosed with AIDS during childhood.

Simard EP, Shiels MS, Bhatia K, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):148-54. doi: 10.1158/1055-9965.EPI-11-0823.


AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 Apr;16(4):441-51, 456, 459. Review.


Cancer in HIV-infected persons from the Caribbean, Central and South America.

Fink VI, Shepherd BE, Cesar C, Krolewiecki A, Wehbe F, Cortés CP, Crabtree-Ramírez B, Padgett D, Shafaee M, Schechter M, Gotuzzo E, Bacon M, McGowan C, Cahn P, Masys D; Caribbean Central South America Network for HIV Research Collaboration of the International Epidemiologic Databases to Evaluate AIDS Program..

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):467-73. doi: 10.1097/QAI.0b013e31820bb1c3.


Cancer burden in the HIV-infected population in the United States.

Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA.

J Natl Cancer Inst. 2011 May 4;103(9):753-62. doi: 10.1093/jnci/djr076.


Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.

Muñoz A, Schrager LK, Bacellar H, Speizer I, Vermund SH, Detels R, Saah AJ, Kingsley LA, Seminara D, Phair JP.

Am J Epidemiol. 1993 Feb 15;137(4):423-38.


[AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].

Tserenpuntsag B, Kołacińska A, Jabłonowska E.

Przegl Epidemiol. 2007;61(3):529-34. Review. Polish.


Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.

Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C, Dehler S, Jundt G, Ess S, Bordoni A, Konzelmann I, Frick H, Dal Maso L, Elzi L, Furrer H, Calmy A, Cavassini M, Ledergerber B, Keiser O; Swiss HIV Cohort Study..

Br J Cancer. 2010 Jul 27;103(3):416-22. doi: 10.1038/sj.bjc.6605756.

Items per page

Supplemental Content

Support Center